Literature DB >> 14723954

Structure-activity relationships of globomycin analogues as antibiotics.

Toshihiro Kiho1, Mizuka Nakayama, Kayo Yasuda, Shunichi Miyakoshi, Masatoshi Inukai, Hiroshi Kogen.   

Abstract

Globomycin (1a), a signal peptidase II inhibitor, and its derivatives show potent antibacterial activity against Gram-negative bacteria. The synthesis and antimicrobial activity of novel globomycin analogues are reported. The hydroxyl group in the L-Ser residue was essential for the antimicrobial activity and the length of the alkyl side chain greatly influenced the activity. In addition, derivatives that had a modified cyclic core exhibited weak activity. One of the analogues showed a wider antimicrobial spectrum, effective against not only Gram-negative but also Gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723954     DOI: 10.1016/j.bmc.2003.10.055

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

Review 1.  Protein export systems of Mycobacterium tuberculosis: novel targets for drug development?

Authors:  Meghan E Feltcher; Jonathan Tabb Sullivan; Miriam Braunstein
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

Review 2.  Bacterial proteases, untapped antimicrobial drug targets.

Authors:  Elizabeth Culp; Gerard D Wright
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

Review 3.  Ligand binding at the protein-lipid interface: strategic considerations for drug design.

Authors:  Jian Payandeh; Matthew Volgraf
Journal:  Nat Rev Drug Discov       Date:  2021-07-13       Impact factor: 84.694

4.  A unique Coxiella burnetii lipoprotein involved in metal binding (LimB).

Authors:  James M Battisti; Linda D Hicks; Michael F Minnick
Journal:  Microbiology (Reading)       Date:  2011-01-06       Impact factor: 2.777

Review 5.  Enatiomerically pure hydroxycarboxylic acids: current approaches and future perspectives.

Authors:  Qun Ren; Katinka Ruth; Linda Thöny-Meyer; Manfred Zinn
Journal:  Appl Microbiol Biotechnol       Date:  2010-06       Impact factor: 4.813

6.  Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins.

Authors:  Haibin Huang; Mingqun Lin; Xueqi Wang; Takane Kikuchi; Heather Mottaz; Angela Norbeck; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

Review 7.  A phylum level analysis reveals lipoprotein biosynthesis to be a fundamental property of bacteria.

Authors:  Iain C Sutcliffe; Dean J Harrington; Matthew I Hutchings
Journal:  Protein Cell       Date:  2012-03       Impact factor: 14.870

8.  Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin.

Authors:  Samir Olatunji; Xiaoxiao Yu; Jonathan Bailey; Chia-Ying Huang; Marta Zapotoczna; Katherine Bowen; Maja Remškar; Rolf Müller; Eoin M Scanlan; Joan A Geoghegan; Vincent Olieric; Martin Caffrey
Journal:  Nat Commun       Date:  2020-01-09       Impact factor: 14.919

Review 9.  Mode of action of lipoprotein modification enzymes-Novel antibacterial targets.

Authors:  Simon Legood; Ivo G Boneca; Nienke Buddelmeijer
Journal:  Mol Microbiol       Date:  2020-10-12       Impact factor: 3.501

Review 10.  Bacterial Lipoprotein Posttranslational Modifications. New Insights and Opportunities for Antibiotic and Vaccine Development.

Authors:  Luke Smithers; Samir Olatunji; Martin Caffrey
Journal:  Front Microbiol       Date:  2021-12-07       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.